CAS ID: | 51-48-9 |
Molecular Formula: | C15H11I4NO4 |
Molecular Weight: | 776.9 g/mol |
Monoisotopic Mass: | 776.6867 g/mol |
Class: | Small Molecule |
Natural Product: | No |
Other Names: | LEVOTHYROXINE SODIUM | LEVOLET | LEVO-T | LEVOXYL | Tetramet | Levothyroid | Soloxine | UNITHROID | T4 | TIROSINT | SYNTHROID | Levothyroxine | LEVOTHROID | EVOTROX | THYROXINE | TIROSINT-SOL | Thyrol L | ELTROXIN | L-THYROXINE HENNING | T4 (LIOTRIX) | THYROXINE I 131 | NOVOTHYROX | THYRO-TABS | THYROXINE I 125 | Levoxine |
Analysis: | Drug repositioning mechanism analysis |
Trial Record 1
ClinicalTrial ID | NCT02512978 | Disease | Cardiac fibrosis |
Phase | Phase 4 | Status | Recruiting |
First Received | July 31, 2015 | Last Verified | July 16, 2018 |
Sponsor | Chinese Academy of Medical Sciences, Fuwai Hospital |
PubChem: | 5819 |
ChEMBL: | CHEMBL1624 |